<sup>1</sup>H HR-MAS NMR-Based Metabolomics of Cancer Cells in Response to Treatment with the Diruthenium Trithiolato Complex [(<i>p</i>-MeC<sub>6</sub>H<sub>4</sub><i><sup>i</sup></i>Pr)<sub>2</sub>Ru<sub>2</sub>(SC<sub>6</sub>H<sub>4</sub>-<i>p</i>-Bu<i><sup>t</sup></i>)<sub>3</sub>]<sup>+</sup> (DiRu-1)
The trithiolato bridged diruthenium complex DiRu-1 [(<i>p</i>-MeC<sub>6</sub>H<sub>4</sub><i><sup>i</sup></i>Pr)<sub>2</sub>Ru<sub>2</sub>(SC<sub>6</sub>H<sub>4</sub>-<i>p</i>-Bu<i><sup>t</sup></i>)<sub>3</sub>]<sup>+</sup> is highly cytotoxic against various cancer cell lines, but its exact mode of...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI AG
2019-07-01
|
| Series: | Metabolites |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-1989/9/7/146 |
| Tags: |
No Tags, Be the first to tag this record!
|